Literature DB >> 8491765

Impaired cytokine production in whole blood cell cultures of patients with urological carcinomas.

U Elsässer-Beile1, S von Kleist, R Fischer, M Martin, U Wetterauer, H Gallati, J S Mönting.   

Abstract

The production of the cytokines interferon gamma (IFN gamma), interleukin-1 alpha (IL-1 alpha) and tumor necrosis factor alpha (TNF alpha) was investigated in the mitogen-stimulated whole blood cell culture media from 51 patients with urinary bladder carcinomas, 52 patients with renal carcinomas, 31 patients with prostatic carcinomas and 360 healthy controls. The cytokines were measured 4 days after induction by a sensitive enzymo-immunological assay. In the blood cell culture supernatants of the patients with urinary bladder carcinomas significant lower levels of IFN gamma (P < or = 0.001), IL-2 (P < or = 0.01) and TNF alpha (P < or = 0.05) were found as compared to the controls. Blood cells of patients with renal carcinomas had lower production of IFN gamma (P < or = 0.01), IL-2 (P < or = 0.001) and IL-1 alpha (P < or = 0.01), whereas the values of the total group of patients with prostatic carcinomas were not significantly different from those of the controls. Lymphocyte and monocyte counts were almost identical in the control and all tumor patient groups. When the patients with renal carcinomas and prostatic carcinomas were analyzed according to their different clinical stages we could show a gradual depression of the IFN-gamma levels, which was related to tumor burden.

Entities:  

Mesh:

Substances:

Year:  1993        PMID: 8491765     DOI: 10.1007/BF01218426

Source DB:  PubMed          Journal:  J Cancer Res Clin Oncol        ISSN: 0171-5216            Impact factor:   4.553


  19 in total

1.  Clinical studies on cell-mediated immunity in patients with urinary bladder carcinoma: blastogenic response, interleukin-2 production and interferon-gamma production of lymphocytes.

Authors:  S Ikemoto; T Kishimoto; S Wada; S Nishio; M Maekawa
Journal:  Br J Urol       Date:  1990-04

2.  Impaired production of tumor necrosis factor in breast cancer.

Authors:  C C Zielinski; C Mueller; E Tyl; E Tichatschek; E Kubista; J Spona
Journal:  Cancer       Date:  1990-11-01       Impact factor: 6.860

3.  Critical evaluation of lymphocyte functions in urological cancer patients.

Authors:  M M Elhilali; K D Paika; S Brosman; J L Fahey
Journal:  Cancer Res       Date:  1976-01       Impact factor: 12.701

4.  Defect in lectin-induced interleukin 2 production by peripheral blood lymphocytes of patients with invasive urinary bladder carcinoma.

Authors:  J Bubeník; J Kieler; V Tromholt; G Hermann; T Jandlová
Journal:  Immunol Lett       Date:  1988-06       Impact factor: 3.685

5.  Heightened interferon-gamma production by mononuclear cells from bladder cancer patients.

Authors:  A Shapiro; T L Ratliff; D R Kelley; W J Catalona
Journal:  Cancer Res       Date:  1984-07       Impact factor: 12.701

6.  Impaired cytokine production in whole blood cell cultures from patients with colorectal carcinomas as compared to benign colorectal tumors and controls.

Authors:  U Elsässer-Beile; S von Kleist; R Fischer; J S Mönting
Journal:  J Clin Lab Anal       Date:  1992       Impact factor: 2.352

7.  Diminished interleukin-2 activity production in cancer patients bearing solid tumors and its relationship with natural killer cells.

Authors:  A Rey; B Klein; D Zagury; C Thierry; B Serrou
Journal:  Immunol Lett       Date:  1983-03       Impact factor: 3.685

8.  Preoperative and postoperative immunological evaluation of patients with colorectal cancer.

Authors:  M Shafir; J G Bekesi; A Papatestas; G Slater; A H Aufses
Journal:  Cancer       Date:  1980-08-15       Impact factor: 6.860

9.  The relative proliferation index as a more sensitive parameter for evaluating lymphoproliferative responses of cancer patients to mitogens and alloantigens.

Authors:  J H Dean; R Connor; R B Herberman; J Silva; J L McCoy; R K Oldham
Journal:  Int J Cancer       Date:  1977-09-15       Impact factor: 7.396

10.  Production of and response to interleukin-2 in peripheral blood lymphocytes of cancer patients.

Authors:  H J Wanebo; R Pace; S Hargett; D Katz; J Sando
Journal:  Cancer       Date:  1986-02-01       Impact factor: 6.860

View more
  2 in total

Review 1.  Immunosuppression in human tumor-host interaction: role of cytokines and alterations in signal-transducing molecules.

Authors:  R Kiessling; K Kono; M Petersson; K Wasserman
Journal:  Springer Semin Immunopathol       Date:  1996

2.  Selective suppression of cytokine secretion in whole blood cell cultures of patients with colorectal cancer.

Authors:  H Lahm; M Schindel; L Frikart; J P Cerottini; A Yilmaz; J C Givel; J R Fischer
Journal:  Br J Cancer       Date:  1998-10       Impact factor: 7.640

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.